The ROC curves (Fig. 3G,H) revealed that in the subjects carrying the risk genotype of rs10738605, the expression of ANRIL was capable of separating premature CAD from non-CAD subjects with a sensitivity of 83%. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.